News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
TapImmune Inc. Appoints Dr. Robert Florkiewicz as Senior Director of Molecular Biology & Virology
April 11, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SEATTLE, April 11, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) has announced that Robert Florkiewicz, Ph.D., has been appointed Senior Director of Molecular Biology & Virology.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Layoff Tracker
Bayer’s BlueRock Lays Off 50 in Streamlining Effort
June 26, 2025
·
148 min read
·
BioSpace Editorial Staff
IN PARTNERSHIP WITH PATSNAP
Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter
June 25, 2025
·
1 min read
·
BioSpace Insights
GLP-1
Prescription Drug Sales Will Hit $1.75T By 2030 Thanks to GLP-1s: Evaluate
June 25, 2025
·
3 min read
·
Annalee Armstrong
Collaboration
Sanofi, Gilead Deepen Protein Degrader Pipelines in Separate Deals With Kymera
June 25, 2025
·
2 min read
·
Tristan Manalac
